328546-98-1 Usage
Uses
Used in Pharmaceutical Industry:
3-(4-BROMO-PHENYL)-PYRROLIDINE is used as a starting material or intermediate in organic synthesis for the development of pharmaceuticals. Its unique structure and reactivity make it a valuable component in the creation of new drug formulations.
Used in Drug Formulation Development:
3-(4-BROMO-PHENYL)-PYRROLIDINE is used as a key component in the formulation of new drugs, where its properties and reactivity can be harnessed to improve the efficacy and safety of the final product. Its precise role in drug formulation will depend on the specific context and requirements of the pharmaceutical development process.
Check Digit Verification of cas no
The CAS Registry Mumber 328546-98-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,2,8,5,4 and 6 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 328546-98:
(8*3)+(7*2)+(6*8)+(5*5)+(4*4)+(3*6)+(2*9)+(1*8)=171
171 % 10 = 1
So 328546-98-1 is a valid CAS Registry Number.
InChI:InChI=1/C10H12BrN/c11-10-3-1-8(2-4-10)9-5-6-12-7-9/h1-4,9,12H,5-7H2
328546-98-1Relevant academic research and scientific papers
LINCOSAMIDE DERIVATIVE, AND ANTIBACTERIAL AGENT COMPRISING THE SAME AS ACTIVE INGREDIENT
-
Page/Page column 28, (2010/04/24)
An objective of the present invention is to provide compounds of formula (I) or their pharmacologically acceptable salts or solvates wherein A represents aryl while R1 represents a five- or six-membered monocyclic heterocyclic group, or A represents a four- to six-membered monocyclic heterocyclic group while R1 represents aryl or a five- or six-membered monocyclic heterocyclic group; R2 represents a hydrogen atom or C1-6 alkyl; R3 represents C1-6 alkyl or C3-6 cycloalkyl-C1-4 alkyl; R4, R5, and R6 represent a hydrogen atom; R7 represents C1-6 alkyl; and m is 1 to 3. The compounds are novel lincosamide derivatives that have a potent activity against resistant Streptococcus pneumoniae. Further, the compounds are usable as antimicrobial agents and are useful for preventing or treating bacterial infectious diseases.
